AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,969,000 | +33.7% | 1,319,893 | -33.7% | 0.00% | +50.0% |
| Q2 2022 | $14,934,000 | -47.9% | 1,991,084 | -36.8% | 0.00% | -50.0% |
| Q1 2022 | $28,647,000 | +1.2% | 3,148,069 | -21.9% | 0.00% | +33.3% |
| Q4 2021 | $28,302,000 | +11.8% | 4,031,555 | +81.6% | 0.00% | 0.0% |
| Q3 2021 | $25,310,000 | -15.2% | 2,220,236 | +19.1% | 0.00% | -25.0% |
| Q2 2021 | $29,853,000 | -4.2% | 1,864,630 | +6.9% | 0.00% | -20.0% |
| Q1 2021 | $31,157,000 | +31.9% | 1,743,482 | -0.3% | 0.01% | +25.0% |
| Q4 2020 | $23,622,000 | +35.6% | 1,748,448 | +18.1% | 0.00% | +33.3% |
| Q3 2020 | $17,421,000 | -4.5% | 1,480,168 | +19.8% | 0.00% | -25.0% |
| Q2 2020 | $18,242,000 | +86.4% | 1,235,961 | +70.5% | 0.00% | +33.3% |
| Q1 2020 | $9,788,000 | -51.3% | 725,107 | -12.8% | 0.00% | -40.0% |
| Q4 2019 | $20,100,000 | +37.0% | 831,619 | +8.9% | 0.01% | +25.0% |
| Q3 2019 | $14,673,000 | -5.2% | 763,408 | +45.7% | 0.00% | 0.0% |
| Q2 2019 | $15,479,000 | -36.0% | 523,840 | +2.9% | 0.00% | -42.9% |
| Q1 2019 | $24,174,000 | +49.8% | 508,912 | +13.9% | 0.01% | +40.0% |
| Q4 2018 | $16,135,000 | -28.4% | 446,936 | +22.0% | 0.01% | -16.7% |
| Q3 2018 | $22,544,000 | -28.6% | 366,266 | -21.6% | 0.01% | -33.3% |
| Q2 2018 | $31,567,000 | -26.1% | 467,300 | -40.6% | 0.01% | -25.0% |
| Q1 2018 | $42,694,000 | +25.7% | 786,970 | +38.4% | 0.01% | +33.3% |
| Q4 2017 | $33,962,000 | +598.8% | 568,420 | +468.4% | 0.01% | +800.0% |
| Q3 2017 | $4,860,000 | -33.3% | 100,012 | -27.9% | 0.00% | -50.0% |
| Q2 2017 | $7,289,000 | -13.2% | 138,680 | -25.1% | 0.00% | +100.0% |
| Q1 2017 | $8,402,000 | -12.8% | 185,248 | -27.2% | 0.00% | -50.0% |
| Q4 2016 | $9,630,000 | +317.1% | 254,402 | +315.8% | 0.00% | +100.0% |
| Q3 2016 | $2,309,000 | +200.3% | 61,186 | +40.0% | 0.00% | – |
| Q2 2016 | $769,000 | +161.6% | 43,716 | +80.5% | 0.00% | – |
| Q1 2016 | $294,000 | +5.0% | 24,224 | +111.0% | 0.00% | – |
| Q4 2015 | $280,000 | -62.6% | 11,480 | -72.8% | 0.00% | – |
| Q3 2015 | $748,000 | -44.4% | 42,162 | -44.7% | 0.00% | – |
| Q2 2015 | $1,345,000 | -33.7% | 76,203 | +17.7% | 0.00% | -100.0% |
| Q1 2015 | $2,029,000 | +314.1% | 64,747 | +286.4% | 0.00% | – |
| Q4 2014 | $490,000 | +21.6% | 16,757 | -14.0% | 0.00% | – |
| Q3 2014 | $403,000 | +90.1% | 19,492 | +128.5% | 0.00% | – |
| Q2 2014 | $212,000 | +101.9% | 8,532 | +71.9% | 0.00% | – |
| Q1 2014 | $105,000 | -73.8% | 4,964 | -77.8% | 0.00% | – |
| Q4 2013 | $400,000 | – | 22,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|